
Conference Coverage
Latest Content

Kerry Rogers, MD, Talks BTK Inhibitor Sequencing, Cost, Access in CLL

FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer

New Agents Aim to Close Gaps in Chronic Hand Eczema Care

CVI Range Assessment Validated as Reliable Measure of Functional Vision in Children

MS Likely Unfolds Along a Continuum Years Before First Symptoms

Shorts










Podcasts
Center on Health Equity & Access
All News

KFF poll links social media use and not having a trusted doctor to vaccine myth beliefs, fueling COVID-19 and measles risk.

CMS's enforcement surge has put every Medicaid Fraud Control Unit under review, but experts say the bigger driver of coverage loss may be red tape.

New Legionnaires disease cases in NYC's Upper East Side cluster have declined as officials continue cooling tower remediation and investigation.

Female newborns were more likely than males to miss vitamin K prophylaxis and hepatitis B birth doses, highlighting sex-based gaps in preventive care.

June author Erin L. Duffy, PhD, MPH, discusses her study showing nonprofit and system-affiliated hospitals provide greater access to translated financial assistance documents.

The FDA approved LEQEMBI IQLIK for once-weekly at-home subcutaneous initiation in early Alzheimer's disease based on IV and extension study data.

Families face lasting financial burdens after pediatric cancer, underscoring the need for paid leave, survivorship resources, and financial navigation.

The 2026 State of Dry Eye survey links DED treatment to improved emotional well-being and quality of life amid delays in care and awareness gaps.

JAK inhibitors are reshaping alopecia areata care, while global registries aim to address long-term safety and effectiveness data gaps.

Alexander Spira, MD, PhD, FACP, FASCO, explains why sarcoma treatment lags behind other solid tumors and the access, subtype, and biomarker barriers.





















